Effect of haishengsu preparation extracted from Tegillarca granosa in treatment of intermediate and late non-small-cell lung cancer (NSCLC) and late renal cancer / 中国海洋药物

ABSTRACT

Objective To observe the effect of haishengsu preparation extracted from Tegillarca granosa on patients with NSCLC and renal cancer that lose the opportunity of operation, radical cure or large dose chemotherapy. Methods 61 cases of NSCLC and 27 cases of renal cancer patients received the haishengsu injection 2.4mg+0.9%NaCl 250ml iv once daily for a consecutive 20 days. 28 days was considered one treatment cycle and each case received 3 to 6 cycles respectively.Results In NSCLC patients,2 cases completely remitted (CR), 28 cases of partially remitted (PR) with the total effective rate of 49.18%. Curative effects in cases with initial treatment, IIIb stage, adenocarcinoma or high behavior condition were higher than those of cases with retreatment, Ⅳ stage, squamous carcinoma, or low behavior condition respectively (P